Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer

Thromboembolism is a compelling challenge in cancer care because of its life-threatening nature as well as its impact on specific treatments. Current guidelines do not generally recommend antithrombotic prophylaxis, except in selected categories of patients at high risk of thrombosis. Accordingly, s...

Descripción completa

Detalles Bibliográficos
Otros Autores:	Ferroni, Patrizia (Editor), Roselli, Mario (Otro), Guadagni, Fiorella
Formato:	Libro electrónico
Idioma:	Inglés
Publicado:	Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Materias:	Medicine Oncology multiple myeloma venous thromboembolism risk assessment models thromboprophylaxis direct oral anticoagulants cancer-associated venous thromboembolism thrombosis pulmonary embolism neoplasms anticoagulants coumarins low molecular weight heparins cancer endogenous heparin heparanase heparan sulfate hospice palliative care units low molecular weight heparin deep vein thrombosis cancer associated thrombosis VTE malignancy direct oral anticoagulant pancreatic cancer low-molecular weight heparin survival coagulation activation locally advanced breast cancer prognostic model pCR treatment prophylaxis DOAC simultaneous care integrated care lymphoma Non-Hodgkin lymphoma Hodgkin lymphoma risk factors molecular subtype arterial thrombosis ALK ROS1 KRAS chemotherapy low-molecular-weight heparin (LMWH) VKA UFH DOACs
Ver en Biblioteca Universitat Ramon Llull:	https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009672609806719